Variant report

Variant	esv3382920
Chromosome Location	chr5:1927852-1931550
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:75)
CpG islands
(count:367)
Chromatin interactive
region (count:1)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:75 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:1931242-1932154	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr5:1930222-1930375	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr5:1928552-1928667	HepG2	liver:	n/a	chr5:1928599-1928610 chr5:1928598-1928611
4	CHD1	chr5:1931546-1931606	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr5:1931533-1931640	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTBP2	chr5:1931111-1932029	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr5:1930404-1930410	GM19239	blood:	n/a	n/a
8	CTCF	chr5:1929776-1929814	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr5:1930421-1930566	GM19239	blood:	n/a	n/a
10	CTCF	chr5:1929718-1929720	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr5:1929301-1929371	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr5:1929709-1930029	NHEK	skin:	n/a	n/a
13	CTCF	chr5:1930169-1930265	NHEK	skin:	n/a	n/a
14	CTCF	chr5:1929185-1930322	GM19239	blood:	n/a	n/a
15	CTCF	chr5:1929366-1929400	NHEK	skin:	n/a	n/a
16	CTCF	chr5:1929633-1929712	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr5:1930413-1930418	GM19239	blood:	n/a	n/a
18	CTCF	chr5:1931160-1931310	NHEK	skin:	n/a	n/a
19	EGR1	chr5:1931137-1931583	H1-hESC	embryonic stem cell:	n/a	chr5:1931259-1931268 chr5:1931258-1931271 chr5:1931258-1931271
20	GABPA	chr5:1929834-1930182	K562	blood:	n/a	n/a
21	GABPA	chr5:1931141-1931648	H1-hESC	embryonic stem cell:	n/a	n/a
22	JUND	chr5:1931312-1931380	H1-hESC	embryonic stem cell:	n/a	n/a
23	MAFK	chr5:1930226-1930299	H1-hESC	embryonic stem cell:	n/a	n/a
24	MAX	chr5:1929326-1930108	NB4	blood:	n/a	n/a
25	MAX	chr5:1929231-1930154	HUVEC	blood vessel:	n/a	n/a
26	MAX	chr5:1930809-1931676	H1-hESC	embryonic stem cell:	n/a	n/a
27	MAX	chr5:1931269-1931728	H1-hESC	embryonic stem cell:	n/a	n/a
28	MAZ	chr5:1929637-1929658	Hela-S3	cervix:	n/a	n/a
29	MAZ	chr5:1929467-1929642	HepG2	liver:	n/a	n/a
30	MYC	chr5:1929666-1929939	MCF-7	breast:	n/a	n/a
31	MYC	chr5:1929441-1929518	GM12878	blood:	n/a	n/a
32	MYC	chr5:1930076-1930131	H1-hESC	embryonic stem cell:	n/a	n/a
33	MYC	chr5:1930235-1930268	MCF-7	breast:	n/a	n/a
34	MYC	chr5:1929942-1929955	MCF-7	breast:	n/a	n/a
35	MYC	chr5:1930233-1930289	HUVEC	blood vessel:	n/a	n/a
36	MYC	chr5:1929700-1929837	MCF-7	breast:	n/a	n/a
37	MYC	chr5:1930285-1930286	MCF-7	breast:	n/a	n/a
38	MYC	chr5:1929257-1929284	HUVEC	blood vessel:	n/a	n/a
39	MYC	chr5:1930845-1931365	MCF10A-Er-Src	breast:	n/a	n/a
40	MYC	chr5:1929151-1929210	GM12878	blood:	n/a	n/a
41	NFATC1	chr5:1929891-1930456	GM12878	blood:	n/a	n/a
42	NR2C2	chr5:1929198-1930575	GM12878	blood:	n/a	n/a
43	PBX3	chr5:1930214-1930384	GM12878	blood:	n/a	n/a
44	POLR2A	chr5:1928300-1932687	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr5:1930210-1930258	Gliobla	brain:	n/a	n/a
46	POLR2A	chr5:1929301-1929316	Gliobla	brain:	n/a	n/a
47	POLR2A	chr5:1929600-1930181	Gliobla	brain:	n/a	n/a
48	POLR2A	chr5:1929369-1929669	HepG2	liver:	n/a	n/a
49	POLR2A	chr5:1929564-1929678	A549	lung:	n/a	n/a
50	POLR2A	chr5:1929763-1929890	MCF-7	breast:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:1931544-1931594	GM12891	blood:	n/a
2	chr5:1931544-1931594	GM12891	blood:	n/a
3	chr5:1930801-1930851	AG10803	skin:	n/a
4	chr5:1931058-1931108	T-47D	breast:	n/a
5	chr5:1930928-1930978	HRPEpiC	eye:	n/a
6	chr5:1931251-1931301	NB4	blood:	n/a
7	chr5:1931058-1931108	AG04450	lung:	fetal
8	chr5:1931544-1931594	HCT-116	colon:	n/a
9	chr5:1930801-1930851	LNCaP	prostate:	n/a
10	chr5:1930801-1930851	AG09319	gingival:	n/a
11	chr5:1931376-1931426	GM12891	blood:	n/a
12	chr5:1931376-1931426	HRE	kidney:	n/a
13	chr5:1930801-1930851	HCF	heart:	n/a
14	chr5:1931376-1931426	AoSMC	blood vessel:	n/a
15	chr5:1931251-1931301	U87	brain:	n/a
16	chr5:1931251-1931301	HRPEpiC	eye:	n/a
17	chr5:1931058-1931108	IMR90	lung:	fetal
18	chr5:1931544-1931594	H1-hESC	embryonic stem cell:	embryo
19	chr5:1931376-1931426	SKMC	muscle:	n/a
20	chr5:1931544-1931594	HepG2	liver:	n/a
21	chr5:1930928-1930978	RPTEC	kidney:	n/a
22	chr5:1931544-1931594	AG09309	skin:	n/a
23	chr5:1931544-1931594	BE2_C	brain:	n/a
24	chr5:1930928-1930978	H1-hESC	embryonic stem cell:	embryo
25	chr5:1930801-1930851	SK-N-SH_RA	brain:	n/a
26	chr5:1931251-1931301	RPTEC	kidney:	n/a
27	chr5:1931251-1931301	BJ	skin:	n/a
28	chr5:1931544-1931594	MCF-7	breast:	n/a
29	chr5:1931251-1931301	GM12892	blood:	n/a
30	chr5:1931251-1931301	HL-60	blood:	n/a
31	chr5:1931058-1931108	HMEC	breast:	n/a
32	chr5:1930928-1930978	LNCaP	prostate:	n/a
33	chr5:1930928-1930978	SK-N-SH_RA	brain:	n/a
34	chr5:1930801-1930851	HEEpiC	esophagus:	n/a
35	chr5:1931544-1931594	NB4	blood:	n/a
36	chr5:1931376-1931426	AG10803	skin:	n/a
37	chr5:1930928-1930978	CMK	blood:	n/a
38	chr5:1931376-1931426	HNPCEpiC	eye:	n/a
39	chr5:1931376-1931426	GM06990	blood:	n/a
40	chr5:1930801-1930851	GM06990	blood:	n/a
41	chr5:1931058-1931108	HRCEpiC	kidney:	n/a
42	chr5:1931251-1931301	Hepatocyte	liver:	n/a
43	chr5:1931058-1931108	HCT-116	colon:	n/a
44	chr5:1931544-1931594	HNPCEpiC	eye:	n/a
45	chr5:1930801-1930851	ECC-1	luminal epithelium:	n/a
46	chr5:1931251-1931301	MCF10A-Er-Src	breast:	n/a
47	chr5:1930928-1930978	SK-N-MC	brain:	n/a
48	chr5:1931251-1931301	BE2_C	brain:	n/a
49	chr5:1931058-1931108	Hepatocyte	liver:	n/a
50	chr5:1930928-1930978	HPAEpiC	pulmonary alveolar:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:1928752..1930799-chr5:1946292..1948777,2	MCF-7	breast:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IRX4-2	chr5:1929770-1930148	NONHSAT100080
2	lnc-IRX4-2	chr5:1929007-1930243	XLOC_004707
3	lnc-IRX4-2	chr5:1930518-1930577	XLOC_004707
4	lnc-NDUFS6-5	chr5:1931298-1931503	XLOC_004250
5	lnc-NDUFS6-5	chr5:1931371-1931503	XLOC_004250
6	lnc-NDUFS6-5	chr5:1931105-1931503	XLOC_004250
7	lnc-IRX4-2	chr5:1929182-1929710	NONHSAT100080
8	lnc-NDUFS6-5	chr5:1931131-1931503	XLOC_004250

No data

Variant related genes	Relation type
ENSG00000248994	TF binding region
ENSG00000248994	CpG island
PFAS	miRNA target sites
UTP15	miRNA target sites
UTRN	miRNA target sites

Extended variants
information (count: 241 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:241 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs559651159	chr5:1927865-1927866	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs572270752	chr5:1927875-1927876	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs542870905	chr5:1927898-1927899	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs536848645	chr5:1927955-1927956	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs375379869	chr5:1927956-1927957	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs560956465	chr5:1927969-1927970	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs558741308	chr5:1927970-1927971	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs531511233	chr5:1927978-1927979	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs9885094	chr5:1927979-1927980	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs577193174	chr5:1927981-1927982	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs372281639	chr5:1927995-1927996	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs4285271	chr5:1928013-1928014	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs146676254	chr5:1928036-1928037	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs559704844	chr5:1928043-1928044	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs574436743	chr5:1928048-1928049	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs564962195	chr5:1928072-1928073	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs532202907	chr5:1928076-1928077	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs140173577	chr5:1928083-1928084	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs186405504	chr5:1928143-1928144	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs536560176	chr5:1928156-1928157	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs548850855	chr5:1928163-1928164	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs369440228	chr5:1928187-1928188	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs569946742	chr5:1928194-1928195	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs56099636	chr5:1928254-1928255	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs199978162	chr5:1928257-1928258	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs558669412	chr5:1928258-1928259	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs541818785	chr5:1928266-1928267	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs191314018	chr5:1928353-1928354	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs182609156	chr5:1928354-1928355	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs188028043	chr5:1928393-1928394	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs191409518	chr5:1928448-1928449	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs183500250	chr5:1928460-1928461	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs563226408	chr5:1928470-1928471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs542583392	chr5:1928493-1928494	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs559880356	chr5:1928512-1928513	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs530677981	chr5:1928532-1928533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs552474464	chr5:1928590-1928591	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs561162907	chr5:1928624-1928625	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs377633852	chr5:1928657-1928658	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs6555029	chr5:1928696-1928697	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs7442693	chr5:1928719-1928720	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs148261043	chr5:1928735-1928736	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs114595842	chr5:1928742-1928743	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs2012991	chr5:1928746-1928747	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs2012990	chr5:1928750-1928751	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs187824039	chr5:1928779-1928780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs192210832	chr5:1928785-1928786	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs559119939	chr5:1928840-1928841	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs372664216	chr5:1928855-1928856	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs150316204	chr5:1928864-1928865	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16608533	CNVD
Cervical cancer	16585170	CNVD
Glioblastoma multiforme	22286061	CNVD
Lung cancer	17925434	CNVD
Ovarian cancer	20844748	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	21829676	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	19181860	CNVD
prenatal diagnosis	20453657	CNVD
Developmental delay	19490664	CNVD
Human papillomavirus	17975027	CNVD
Acute monocytic leukemia	16498392	CNVD
Gastric cancer	16891809	CNVD
Intracranial aneurysm	16715129	CNVD
Emphysema	19352772	CNVD
Chordoma	18071362	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Oral cancer	22144094	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Schizophrenia	23813976	CNVD
Ependymoma	20639864	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:215 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:1924200-1928000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr5:1926200-1929200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr5:1926400-1929200	Weak transcription	Right Atrium	heart
4	chr5:1927000-1928000	Weak transcription	H1 Cell Line	embryonic stem cell
5	chr5:1927200-1928200	Enhancers	H9 Cell Line	embryonic stem cell
6	chr5:1927400-1928000	Enhancers	ES-I3 Cell Line	embryonic stem cell
7	chr5:1927600-1928000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr5:1927800-1928000	Bivalent Enhancer	Fetal Muscle Leg	muscle
9	chr5:1927800-1928200	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr5:1927800-1930400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr5:1928000-1928200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr5:1928000-1928200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr5:1928000-1928200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
14	chr5:1928000-1928200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr5:1928000-1928200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
16	chr5:1928000-1928200	Enhancers	Pancreas	Pancrea
17	chr5:1928000-1928400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
18	chr5:1928000-1928400	Enhancers	H1 Cell Line	embryonic stem cell
19	chr5:1928000-1928400	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr5:1928000-1928400	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr5:1928000-1928400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr5:1928200-1928400	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
23	chr5:1928200-1928400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr5:1928200-1929200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
25	chr5:1928200-1929200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr5:1928200-1929200	Weak transcription	H9 Cell Line	embryonic stem cell
27	chr5:1928200-1929200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr5:1928200-1929200	Weak transcription	Esophagus	oesophagus
29	chr5:1928200-1929200	Weak transcription	Pancreas	Pancrea
30	chr5:1928400-1929400	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr5:1928400-1930400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr5:1928800-1930000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr5:1929000-1929200	Weak transcription	Gastric	stomach
34	chr5:1929200-1929600	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr5:1929200-1929600	Genic enhancers	Gastric	stomach
36	chr5:1929200-1929800	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr5:1929200-1930000	ZNF genes & repeats	Spleen	Spleen
38	chr5:1929200-1930200	Enhancers	Breast Myoepithelial Primary Cells	Breast
39	chr5:1929200-1930200	Genic enhancers	Esophagus	oesophagus
40	chr5:1929200-1930400	ZNF genes & repeats	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr5:1929200-1930400	Bivalent/Poised TSS	Fetal Lung	lung
42	chr5:1929200-1930400	Enhancers	Pancreas	Pancrea
43	chr5:1929200-1930400	ZNF genes & repeats	Right Atrium	heart
44	chr5:1929200-1930600	ZNF genes & repeats	H9 Cell Line	embryonic stem cell
45	chr5:1929200-1930600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr5:1929200-1930600	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
47	chr5:1929200-1930600	ZNF genes & repeats	Lung	lung
48	chr5:1929200-1930600	Enhancers	Ovary	ovary
49	chr5:1929200-1930800	Enhancers	Right Ventricle	heart
50	chr5:1929600-1929800	Weak transcription	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links